Product Images Fenofibric Acid

Fenofibric Acid Delayed-Release Capsules are available in a bottle of 500 capsules. Each capsule contains Choline fenofibrate equivalent to 135g of fenofibric acid. It is recommended to dispense in a light-resistant container with a child-resistant closure. Store at 25°C, with excursions permitted to 15 to 30°C. Keep away from moisture and out of the reach of children. See the package insert for full prescribing information regarding the usual dosage. Manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by Slate Run Pharmaceuticals in Columbus, OH. The medication ought to be stored in a sealed bottle with EXP and LOT or serialization data.*

This is a medication in capsule form that should not be accepted or used if the seal over the bottle opening is broken, missing, or compromised. The delayed-release capsule contains Fen Ofl b"c Ac|d %:'J???,??:é'"',"'e, which is equivalent to 135 mg of Del aye d-Release Dipenseinatignt, dispensed in a light-resistant container having a child-resistant closure. It is recommended to store the capsules at a controlled room temperature in a dry place and away from children. The package insert contains the necessary information on the appropriate dosage, and the medication is produced by Slate Run Pharmaceuticals. The text also includes some packaging details such as serial and lot numbers; however, it is missing prescribing information.*

This is a description of Fenofibric Acid Delayed-Release Capsules packaged under the NDC code 70436-168-03. Each capsule contains choline fenofibrate equivalent to 45mg of fenofibric acid. They should be dispensed in a child-resistant, light-resistant container and kept at a controlled room temperature between 15-30°C. These capsules are manufactured in China and distributed by Slate Run Pharmaceuticals in Columbus, OH. The usual dosage information is available in the package insert. There is a caution to avoid accepting the product if the seal over the bottle opening is broken or missing, and it should be kept away from children. Serialization or other data can be printed on the container, but there is no expiration date or lot number given.*

This is a description of Fenofibric Acid Delayed-Release Capsules with NDC 70436-168-06. Each capsule contains Choline fenofibrate equivalent to 45mg of fenofibric acid. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. It should be stored at 25°C with excursions permitted to 15 to 30°C. Please see the package insert for full prescribing information. This was distributed by Slate Run Pharmaceutical and caution should be taken not to accept if the seal over the bottle opening has been broken or is missing. The space should be left for printing the expiration date and LOT number or serialization data.*